When a little aspirin may be enough

Efstathios Kastritis; Meletios A Dimopoulos

doi:10.1182/blood-2011-08-375089

Article2011

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Tina Bagratuni, Efstathios Kastritis, Μαρία Ρούσσου, Dimitrios Christoulas, Efthimios Kostouros, Marianna Politou, Evangelos Terpos, Meletios A Dimopoulos

Article2013

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide‐based regimens

Tina Bagratuni, Efstathios Kastritis, Marianna Politou, Μαρία Ρούσσου, Efthimios Kostouros, Maria Gavriatopoulou, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanelias, Evangelos Terpos, Meletios A Dimopoulos

Letter2022

Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true?

Luca G. Guidotti, Carlo La Vecchia, Massimo Colombo

Article2005

Novel treatments of multiple myeloma

Meletios A Dimopoulos, Αchilles Anagnostopoulos, Evangelos Terpos

Article2018

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Eftathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Marini Tselegkidi, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Despina Fotiou, Asimina Papanikolaou, Charikleia Gakiopoulou, Erasmia Psimenou, Ioanna Tatouli, Ioannis Ntanasis‐Stathopoulos, Tina Bagratuni, Alexandra Papathoma, Marilyn Spyropoulou-Vlachou, Stavroula Giannouli,

When a little aspirin may be enough

Abstract

Discussion(0)

Related publications

Prospective Evaluation of the Risk of Thromboembolic Complications in Patients Treated with Lenalidomide-based Therapy and Genetic Associations

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide‐based regimens

Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true?

Novel treatments of multiple myeloma

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)